There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
In September 2019, a class-action lawsuit was filed against JB7, LLC for allegedly deceptively marketing its Physician’s Choice Collagen Peptides as “the ultimate sports and post recovery protein” and that each serving of the product provides 12 percent of the Daily Value of protein when, according to the complaint, the Daily Value percentage for the product is zero because it is missing one of the nine essential amino acids (tryptophan) and thus is an “incomplete protein.” (McLaughlin et al v. JB7, LLC, Case No. 19-cv-23748, S. D. FL.)
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
Letters alert agencies and organizations to company’s improper marketing.
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
New research points to “no.”
Why disclosures are key to protecting informed consumer choice and competition.